These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17322493)

  • 1. Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegaly.
    Morrison KM; Bidlingmaier M; Stadler S; Wu Z; Skriver L; Strasburger CJ
    Eur J Endocrinol; 2007 Mar; 156(3):331-9. PubMed ID: 17322493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Fukuda I; Hizuka N; Itoh E; Yasumoto K; Ishikawa Y; Murakami Y; Sata A; Takano K
    Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation.
    Khosravi MJ; Diamandi A; Mistry J; Krishna RG; Khare A
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3944-51. PubMed ID: 9398693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency.
    Juul A; Møller S; Mosfeldt-Laursen E; Rasmussen MH; Scheike T; Pedersen SA; Kastrup KW; Yu H; Mistry J; Rasmussen S; Müller J; Henriksen J; Skakkebaek NE
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4408-15. PubMed ID: 9851786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegaly.
    Morrison KM; Wu Z; Bidlingmaier M; Strasburger CJ
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S61-3. PubMed ID: 11527090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Serum Acid-Labile Subunit Alone and in combination with IGF-I and IGFBP-3 in the Diagnosis of Growth Hormone Deficiency.
    Ertl DA; Chen J; Gleiss A; Janu D; Sagmeister S; Raimann A; Riedl S; Haeusler G
    Horm Res Paediatr; 2020; 93(6):371-379. PubMed ID: 33341813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans.
    Stadler S; Wu Z; Dressendörfer RA; Morrison KM; Khare A; Lee PD; Strasburger CJ
    J Immunol Methods; 2001 Jun; 252(1-2):73-82. PubMed ID: 11334967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
    Feelders RA; Bidlingmaier M; Strasburger CJ; Janssen JA; Uitterlinden P; Hofland LJ; Lamberts SW; van der Lely AJ; de Herder WW
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6480-9. PubMed ID: 16159936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly.
    Sneppen SB; Lange M; Pedersen LM; Kristensen L LØ; Main KM; Juul A; Skakkebaek NE; Feldt-Rasmussen U
    Growth Horm IGF Res; 2001 Dec; 11(6):384-91. PubMed ID: 11914026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
    Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
    Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding protein's binding protein--clinical applications of acid-labile subunit (ALS) measurement.
    Baxter RC
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3941-3. PubMed ID: 9398692
    [No Abstract]   [Full Text] [Related]  

  • 20. Acid-labile subunit (ALS) measurements in children.
    Nimura A; Katsumata N; Horikawa R; Tanae A; Tanaka T
    Endocr J; 2000 Mar; 47 Suppl():S111-4. PubMed ID: 10890197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.